UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: follow-up to age 4 years.

CCBennett; AJohnson; DJField; D Elbourne ORCID logo; UK Collaborative ECMO Trial Group; (2001) UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: follow-up to age 4 years. Lancet, 357 (9262). pp. 1094-1096. ISSN 0140-6736 DOI: 10.1016/S0140-6736(00)04310-5
Copy

Extracorporeal membrane oxygenation (ECMO) is a supportive intensive-care technique used for babies with acute respiratory failure. We examined morbidity at age 4 years in surviving children recruited to the UK Collaborative ECMO Trial, and provide long-term data on ECMO support compared with contemporary conventional care. The neonatal ECMO policy resulted in improved survival and a favourable outcome. We therefore advocate the safety and efficacy of this intervention.


Full text not available from this repository.

Explore Further

Read more research from the creator(s):

Find work associated with the faculties and division(s):

Find work associated with the research centre(s):

Find work from this publication: